Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.58B |
| 2 |
Netflix
NFLX
|
+$496M |
| 3 |
Meta Platforms (Facebook)
META
|
+$275M |
| 4 |
Alibaba
BABA
|
+$215M |
| 5 |
UnitedHealth
UNH
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$926M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$682M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$556M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.18% |
| 2 | Technology | 2.09% |
| 3 | Communication Services | 1.44% |
| 4 | Financials | 1.21% |
| 5 | Healthcare | 1.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9726
Lee Enterprises
LEE
$189M
| $52K | ﹤0.01% |
2,545
-5,801
| -70% | -$118K |
|
|
NAGE
9727
CALL
Niagen Bioscience
NAGE
$259M
| $52K | ﹤0.01% |
13,200
-9,700
| -42% | -$41.4K |
|
|
ELOX
9728
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $52K | ﹤0.01% |
+290
| New | +$82.5K |
|
9729
BioCardia
BCDA
$17.1M
| $51K | ﹤0.01% |
+1,021
| New | +$73.3K |
|
9730
PUT
Goldgroup Mining
GORO
$292M
| $51K | ﹤0.01% |
16,700
-1,200
| -7% | -$4.21K |
|
9731
CALL
Marathon Digital Holdings
MARA
$4.57B
| $51K | ﹤0.01% |
29,300
+1,600
| +6% | +$3.23K |
|
9732
Marchex
MCHX
$80M
| $51K | ﹤0.01% |
16,359
-46,560
| -74% | -$179K |
|
9733
Smart Sand
SND
$199M
| $51K | ﹤0.01% |
+18,098
| New | +$45.2K |
|
|
STKL
9734
CALL
DELISTED
SunOpta
STKL
| $51K | ﹤0.01% |
28,100
-3,700
| -12% | -$9.59K |
|
|
MEET
9735
CALL
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $51K | ﹤0.01% |
15,600
-11,600
| -43% | -$40.3K |
|
|
PDLI
9736
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
| $51K | ﹤0.01% |
23,600
-29,400
| -55% | -$78.6K |
|
|
DHY
9737
Credit Suisse High Yield Credit Fund
DHY
$239M
| $50K | ﹤0.01% |
+19,789
| New | +$50K |
|
|
TBHC
9738
DELISTED
The Brand House Collective
TBHC
| $50K | ﹤0.01% |
+32,648
| New | +$50.7K |
|
|
GSS
9739
CALL
DELISTED
Golden Star Resources Ltd.
GSS
| $50K | ﹤0.01% |
17,400
-280,600
| -94% | -$978K |
|
|
NE
9740
PUT
DELISTED
Noble Corporation
NE
| $50K | ﹤0.01% |
39,600
-232,900
| -85% | -$398K |
|
9741
Avalon Holdings
AWX
$10.6M
| $49K | ﹤0.01% |
+22,247
| New | +$52.5K |
|
|
FOCL
9742
CALL
EDAP TMS S.A.
FOCL
$202M
| $49K | ﹤0.01% |
+11,000
| New | +$36.8K |
|
9743
CALL
Indaptus Therapeutics
INDP
$145M
| $49K | ﹤0.01% |
+30
| New | +$89.3K |
|
9744
PUT
Verastem
VSTM
$641M
| $49K | ﹤0.01% |
3,383
+166
| +5% | +$2.7K |
|
|
YI
9745
111 Inc
YI
$33.4M
| $49K | ﹤0.01% |
+1,011
| New | +$40.2K |
|
|
ENT
9746
DELISTED
Global Eagle Entertainment Inc.
ENT
| $49K | ﹤0.01% |
2,723
+253
| +10% | +$4.57K |
|
9747
Baytex Energy
BTE
$3.22B
| $48K | ﹤0.01% |
32,142
-1,108
| -3% | -$1.59K |
|
|
NGD
9748
CALL
DELISTED
New Gold Inc
NGD
| $48K | ﹤0.01% |
48,000
-94,100
| -66% | -$114K |
|
9749
CALL
NLI Holdings
NL
$319M
| $48K | ﹤0.01% |
+12,700
| New | +$50.1K |
|
9750
Comscore
SCOR
$74.9M
| $48K | ﹤0.01% |
1,257
-6,645
| -84% | -$384K |
|
Similar funds
Jeff Yass's Q3 2019 Portfolio in Review
As of Q3 2019, Jeff Yass held 11,380 positions worth $298B, up 8.4% from $275B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $26.9B of net new capital in Q3 2019, opening 1,223 new positions and adding to 4,885 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.8% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $926M trimmed.
- Jeff Yass's largest Q3 2019 buy was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
- Jeff Yass added most to Amazon in Q3 2019, an estimated $1.58B increase.
- Jeff Yass's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $926M.
- Jeff Yass fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $179M.
- Jeff Yass's ten largest holdings make up 24% of its $298B portfolio in Q3 2019.
- Jeff Yass opened 1,223 new positions and closed 1,294 in Q3 2019.
- Jeff Yass's portfolio value rose 8.4% quarter-over-quarter to $298B.
Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.